OBJECTIVE: The aim of this study was to estimate probabilities of achieving the statistical cure from hepatocellular carcinoma (HCC) with hepatic resection (HR) and liver transplantation (LT). BACKGROUND: Statistical cure occurs when the mortality of a specific population returns to values of that of general population. Resection and transplantation are considered potentially curative therapies for HCC, but their effect on the residual entire life-expectancy has never been investigated. METHODS: Data from 3286 HCC patients treated with LT (n = 1218) or HR (n = 2068) were used to estimate statistical cure. Disease-free survival (DFS) was the primary survival measure to estimate cure fractions through a nonmixture model. Overall survival (OS) was a secondary measure. In both, patients were matched with general population by age, sex, year, and race/ethnicity. Cure variations after LT were also adjusted for different waiting-list drop-outs. RESULTS: Considering DFS, the cure fraction after LT was 74.1% and after HR was 24.1% (effect size >0.8). LT outperformed HR within all transplant criteria considered (effect size >0.8), especially for multiple tumors (>0.9) and even in presence of a drop-out up to 20% (>0.5). Considering OS, the cure fraction after LT marginally increased to 75.8%, and after that HR increased to 40.5%. The effect size of LT over HR in terms of cure decreased for oligonodular tumors (<0.5), became small for drop-out up to ∼20% (<0.2), and negligible for single tumors <5 cm (∼0.1). CONCLUSION: As other malignancies, statistical cure can occur for HCC, primarily with LT and secondarily with HR, depending on waiting-list capabilities and efficacy of tumor recurrence therapies after resection.

Liver transplantation and hepatic resection can achieve cure for hepatocellular carcinoma / Pinna, Ad; Yang, T; Mazzaferro, V; De Carlis, L; Zhou, J; Roayaie, S; Shen, F; Sposito, C; Cescon, M; Di Sandro, S; Yi-Feng, H; Johnson, P; Cucchetti, A.. - In: ANNALS OF SURGERY. - ISSN 0003-4932. - 268:5(2018), pp. 868-875. [10.1097/SLA.0000000000002889]

Liver transplantation and hepatic resection can achieve cure for hepatocellular carcinoma

Pinna AD;Di Sandro S;
2018

Abstract

OBJECTIVE: The aim of this study was to estimate probabilities of achieving the statistical cure from hepatocellular carcinoma (HCC) with hepatic resection (HR) and liver transplantation (LT). BACKGROUND: Statistical cure occurs when the mortality of a specific population returns to values of that of general population. Resection and transplantation are considered potentially curative therapies for HCC, but their effect on the residual entire life-expectancy has never been investigated. METHODS: Data from 3286 HCC patients treated with LT (n = 1218) or HR (n = 2068) were used to estimate statistical cure. Disease-free survival (DFS) was the primary survival measure to estimate cure fractions through a nonmixture model. Overall survival (OS) was a secondary measure. In both, patients were matched with general population by age, sex, year, and race/ethnicity. Cure variations after LT were also adjusted for different waiting-list drop-outs. RESULTS: Considering DFS, the cure fraction after LT was 74.1% and after HR was 24.1% (effect size >0.8). LT outperformed HR within all transplant criteria considered (effect size >0.8), especially for multiple tumors (>0.9) and even in presence of a drop-out up to 20% (>0.5). Considering OS, the cure fraction after LT marginally increased to 75.8%, and after that HR increased to 40.5%. The effect size of LT over HR in terms of cure decreased for oligonodular tumors (<0.5), became small for drop-out up to ∼20% (<0.2), and negligible for single tumors <5 cm (∼0.1). CONCLUSION: As other malignancies, statistical cure can occur for HCC, primarily with LT and secondarily with HR, depending on waiting-list capabilities and efficacy of tumor recurrence therapies after resection.
2018
268
5
868
875
Liver transplantation and hepatic resection can achieve cure for hepatocellular carcinoma / Pinna, Ad; Yang, T; Mazzaferro, V; De Carlis, L; Zhou, J; Roayaie, S; Shen, F; Sposito, C; Cescon, M; Di Sandro, S; Yi-Feng, H; Johnson, P; Cucchetti, A.. - In: ANNALS OF SURGERY. - ISSN 0003-4932. - 268:5(2018), pp. 868-875. [10.1097/SLA.0000000000002889]
Pinna, Ad; Yang, T; Mazzaferro, V; De Carlis, L; Zhou, J; Roayaie, S; Shen, F; Sposito, C; Cescon, M; Di Sandro, S; Yi-Feng, H; Johnson, P; Cucchetti, A.
File in questo prodotto:
File Dimensione Formato  
VQR_Liver_Transplantation_and_Hepatic_Resection_can.22.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 269.21 kB
Formato Adobe PDF
269.21 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1202139
Citazioni
  • ???jsp.display-item.citation.pmc??? 53
  • Scopus 107
  • ???jsp.display-item.citation.isi??? 115
social impact